|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.8500 - 1.9950|
|52 Week Range||0.9000 - 2.9700|
|Beta (5Y Monthly)||2.97|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 09, 2020 - Feb 13, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Know Labs, Inc. (OTCQB: KNWN) today reviewed its intellectual property strategy for investors as it moves into the 2020 calendar year. As discussed in its recent annual 10-K filing, the Company has pursued for several years an ambitious intellectual property strategy focused on patent filings, trademarks, copyrights and trade secrets.
Know Labs, Inc. (KNWN) unveiled today a first look at its wearable UBAND™ Continuous Glucose Monitor (CGM) along with its companion iPhone App. Bosua revealed the new UBAND design and iPhone App in this short 1 minute video. UBAND will provide people with an easy, pain-free way to monitor their blood glucose levels.
Know Labs, Inc. (KNWN) – a creator and provider of diagnostic solutions, announced today that Larry K. Ellingson has joined its Medical, Scientific and Regulatory Advisory Board. The Advisory Board was formed to provide counsel and guidance to the Company and its senior management as they work toward FDA approval of their non-invasive UBAND Continuous Glucose Monitor. The Advisory Board is chaired by Know Labs Chief Medical Officer, James (Andy) Anderson, M.D.
Know Labs, Inc. (KNWN) a provider of diagnostic solutions, today announced Racer Technology Pte. Ltd. will manufacture its wearable UBAND Calorie Counter and later its wearable UBAND Continuous Glucose Monitor (CGM). Racer Technology, a medical device and wearables manufacturer, is headquartered in Singapore with factories across Asia. Racer Technology, led by CEO, Willy Koh, has state of the art manufacturing processes and a workforce trained in the latest manufacturing techniques.
Know Labs, Inc. (KNWN) – a creator and provider of diagnostic solutions, announced today the formation of its Medical, Scientific and Regulatory Advisory Board, the initial members of the Advisory Board and its first meeting. The Advisory Board was formed to provide counsel and guidance to the Company and its senior management, CEO Phil Bosua and Chairman and Founder, Ron Erickson. The Advisory Board is chaired by Know Labs Chief Medical Officer, James (Andy) Anderson, M.D.
Know Labs, Inc. (KNWN) a provider of diagnostic solutions, announced today that Mark Tapsak, Ph.D. has joined the Company as Vice President, Intellectual Property. In addition to Dr. Tapsak’s focus on intellectual property at Know Labs he will work to support the product development, manufacturing and launch of the Company’s UBAND Calorie Counter wearable and help drive toward FDA approval of the Company’s non-invasive UBAND Continuous Glucose Monitor. At Dexcom, a multi-billion dollar provider of continuous glucose monitoring (CGM) systems, Dr. Tapsak was the 12th employee.
Know Labs, Inc. (KNWN) – a provider of diagnostic solutions, released today a video presentation of its Bio-RFID™ platform technology’s successful identification of blood alcohol levels. In the video presentation, CEO Phil Bosua not only discusses the Company’s use of Bio-RFID to detect blood alcohol levels, but the broad implications for its technology platform. “Over the last month we’ve been powering through a ton of experiments and innovations and are really happy to report we’ve now got an AI based algorithm that allows our technology to detect blood alcohol levels non-invasively.